Literature DB >> 16440982

Synthesis and antiviral screening of some thieno[2,3-d]pyrimidine nucleosides.

A E Rashad1, M A Ali.   

Abstract

Some cyclic and acyclic nucleosides of thieno[2,3-d]-pyrimidine derivatives were synthesized via the reaction of compounds 1 and 2 or 3 and 4 with 2-chloroethyl methyl ether or 2,3,4, 6-tetra-O-acetyl-alpha-D-glucopyranosyl bromide. Nucleosides 9, 10, 15, and 16 were tested as antiviral agents against herpes simplex virus type-1 (HSV-1) and hepatitis-A virus (HAV). Compound 15 showed the highest effect on HSV-1 than the other three compounds, while the four tested compounds did not show any activity against HAV.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16440982     DOI: 10.1080/15257770500377730

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  4 in total

1.  Thieno[2,3-d]pyrimidinedione derivatives as antibacterial agents.

Authors:  Mahender B Dewal; Amit S Wani; Celine Vidaillac; David Oupický; Michael J Rybak; Steven M Firestine
Journal:  Eur J Med Chem       Date:  2012-02-25       Impact factor: 6.514

Review 2.  A Review on Fused Pyrimidine Systems as EGFR Inhibitors and Their Structure-Activity Relationship.

Authors:  Tanuja T Yadav; Gulam Moin Shaikh; Maushmi S Kumar; Meena Chintamaneni; Mayur Yc
Journal:  Front Chem       Date:  2022-06-13       Impact factor: 5.545

3.  Design, Synthesis, and Biological Activity of Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine Derivatives as Anti-Inflammatory Agents.

Authors:  Yuan Zhang; Lu Luo; Chao Han; Handeng Lv; Di Chen; Guoliang Shen; Kaiqi Wu; Suwei Pan; Faqing Ye
Journal:  Molecules       Date:  2017-11-13       Impact factor: 4.411

4.  Synthesis of Some 4,5-Dihydrothieno[3,2-e][1,2,4]Triazolo[4,3-a] Pyrimi-dine-2-Carboxamides as Anti-Inflammatory and Analgesic Agents.

Authors:  Omaima G Shaaban; Ola H Rizk; Aida E Bayad; Ibrahim M El-Ashmawy
Journal:  Open Med Chem J       Date:  2013-11-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.